Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ownership Breakdown Cumberland Pharmaceuticals Inc. CPIX

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology and oncology. The company promotes its approved products through its hospital, field and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived primarily from the product sales of FDA approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, RediTrex, Sancuso, Vaprisol and Vibativ..


Top institutional share ownership of Cumberland Pharmaceuticals, Inc.

Name Shares Shares % change Value Value % change
Dimensional Fund Advisors Lp 623,867 -0.5% $1,503 15.4%
Renaissance Technologies Llc 596,863 -4.1% $1,438 11.4%
Vanguard Group Inc 374,691 0.0% $903 16.1%
Bridgeway Capital Management Inc 286,655 0.0% $691 16.1%
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares 280,820 0.0% $677 16.2%
BRUSX - Ultra-Small Company Fund Class N 233,068 0.0% $562 16.2%
Acadian Asset Management Llc 188,164 0.0% $451 15.6%
DFFVX - U.S. Targeted Value Portfolio - Institutional Class 161,297 0.0% $363 -4.5%
BlackRock Inc. 140,350 0.1% $338 15.8%
VEXMX - Vanguard Extended Market Index Fund Investor Shares 82,984 0.0% $200 15.7%

Top institutional buyers of Cumberland Pharmaceuticals, Inc.

Name Shares % change Value % change Shares Value
BlackRock Inc. 0.1% 15.8% 140,350 $338

Top institutional sellers of Cumberland Pharmaceuticals, Inc.

Name Shares % change Value % change Shares Value
Two Sigma Advisers, Lp -28.6% -16.7% 24,700 $60
Two Sigma Investments, Lp -12.2% 1.9% 45,215 $109
DFSVX - U.s. Small Cap Value Portfolio - Institutional Class -10.3% -14.9% 38,585 $87
Renaissance Technologies Llc -4.1% 11.4% 596,863 $1,438
FSMAX - Fidelity Extended Market Index Fund -1.2% 11.8% 32,599 $77
Dimensional Fund Advisors Lp -0.5% 15.4% 623,867 $1,503

Information provided by Fintel.io